ilmscore | Prediction Details
"with this acquisition the revenue also will stand to increase there EBITDA margins will improve and overall margins are also set to improve"
By CA Rachana Phadke Ranade | January 22, 2025 | Pending
From video
Mankind Pharma: Fundamental Analysis | Stocks in Focus - Part 3 | CA Rachana Ranade 00:12:32 - 00:12:39
Interpreted Prediction
The acquisition of Bharat Serums and Vaccines Limited is expected to increase Mankind Pharma's revenue and improve its EBITDA and overall margins.

Prediction Details

Ticker
MANKIND

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.